Buydepa has completed an IPO through ScaleX
Buydepa S.p.A. has successfully raised US$3.1 million (CLP3 billion) through its stock market debut on ScaleX (Santiago Venture Exchange). The company placed 12% of its shares through a capital increase, with subscriptions from a local institutional investor and a broad base of high-net-worth qualified investors.
With the funds raised through this placement, Buydepa will allocate 90% to strengthening its equity base, enabling it to secure greater real estate financing, while the remaining 10% will focus on promoting new, asset-light products and incorporating innovative tools to simplify the purchase and sale of properties.
Buydepa has developed a unique business model that focuses on the instant purchase, renovation and sale of properties valued at less than US$142,430 (UF3,500). The company offers recently renovated, semi-new apartments with accessible financing options, including interest-free down payment plans.
Oaklins’ team in Chile acted as the financial advisor and placement agent in the IPO of Buydepa (BCS: BUYDEPAX) through ScaleX. This transaction marks the second placement sponsored by Oaklins Chile on ScaleX, the financing market for start-ups and scale-ups promoted by the Santiago Stock Exchange and Corfo, which currently hosts six listed companies. It further solidifies the team’s position as a leading financial advisor in this market.


Talk to the deal team
Related deals
CustomerXPs Software (Clari5) has been acquired by Perfios Software Solutions
Bengaluru-based SaaS firm Perfios Software Solutions Private Ltd. has acquired 100% of the equity shares in the fraud-detection platform CustomerXPs Software Private Ltd. (Clari5) for an undisclosed amount, enhancing its anti-financial crime management suite for financial institutions.
Learn moreDimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.
Learn moredoValue has finalized a rights issue
doValue has successfully completed a rights issue. The capital increase was implemented to finance doValue’s acquisition of Gardant.
Learn more